Neuroendocrine Cancer Archives - Medical Conferences

NETTER-2: Practice-changing results for 177Lu-DOTATATE in GEP-NETs

Presented By

Dr Simron Singh, University of Toronto, Canada

Trial

Phase 3, NETTER-2

Conference

ASCO GI 2024

Type

News article

13 February 2024 13:03

Head-to-head: Etoposide and irinotecan equally effective in neuroendocrine carcinoma

Presented By

Dr Chigusa Morizane, National Cancer Center Hospital, Japan

Trial

Phase 3, JCOG1213, TOPIC-NEC

Conference

ASCO GI 2022

Type

Peer-reviewed article

21 March 2022 12:26

No benefit of adding axitinib to ocreotide acetate in non-pancreatic neuroendocrine tumours

Presented By

Dr Rocio Garcia-Carbonero, Hospital Universitario 12 de Octubre, Spain

Trial

Phase 3, AXINET trial-GETNE-1107

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 10:44

Phase 2 abemaciclib trial in patients with advanced NETs

Presented By

Prof. Kaylyn Kit Man Wong, University of Washington, USA

Trial

Phase 2

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 10:39

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com